Related Experiment Video
Updated: Aug 13, 2026

05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
[Neck metastases from unknown primary neoplasms (CUP syndrome)]
A Kruk-Zagajewska1, Z Szmeja, M Wierzbicka
1Klinika Otolaryngologii Katedry Chorób Ucha, Nosa, Gardła i Krtani Akademii Medycznej im. K. Marcinkowskiego w Poznaniu.
Otolaryngologia Polska = the Polish Otolaryngology
|September 7, 2000
Summary
Carcinoma of unknown primary (CUP) syndrome involves detecting metastases without a known primary tumor. Identifying head and neck region primaries is crucial for effective CUP syndrome treatment.
Area of Science:
- Oncology
- Pathology
- Head and Neck Surgery
Context:
- Carcinoma of unknown primary (CUP) syndrome presents with histologically confirmed metastases, but the primary tumor site is unknown or diagnosis is delayed.
- Metastases of unknown origin account for 5% to 31% of all neck metastases.
- Squamous cell and anaplastic carcinoma metastases in neck lymphatics often indicate a primary focus within the head and neck region.
Purpose:
- To describe diagnostic procedures for detecting primary foci in Carcinoma of unknown primary syndrome.
- To analyze the utility of understanding lymphatic metastasis spreading routes for primary focus detection.
- To review treatment strategies for CUP syndrome, including neck dissection, radiotherapy, and chemotherapy.
Summary:
- A study of 1348 oncological patients identified 22 cases of CUP syndrome.
- In 15 of these cases, the primary tumor was located in the nasopharynx, palatinal tonsil, tongue, hypopharynx, testes, or breast.
- Seven cases had no primary focus identified despite diagnostic efforts.
Impact:
- Highlights the importance of considering head and neck primaries in CUP syndrome diagnosis.
- Emphasizes the role of diagnostic procedures and knowledge of lymphatic spread in identifying primary tumors.
- Informs treatment approaches, including radical neck dissection, radiotherapy, and chemotherapy, for CUP syndrome.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

